{
    "nctId": "NCT04758416",
    "briefTitle": "Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer",
    "officialTitle": "A Phase II, Single-center STudy on the vAlue of Non-invasive Dual-Pet\uff0818F-FES PET and 68Ga-HER2-Affibody PET\uff09InformatiOn IN Subtype of Metastatic Breast Cancer(MBC)",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Verify the subtype value of dual-PET in extrahepatic metastases",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Subjects voluntarily joined the study, signed informed consent, and had good compliance.\n2. Female patients aged over 18 years (including cutoff value).\n3. an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2.\n4. Recurrence or metastatic breast cancer confirmed by histopathology, or expect to be feasible metastasis puncture or surgery to confirm histopathological recurrence or metastatic breast cancer.\n\nExclusion Criteria:\n\n1. Pregnancy or lactation.\n2. Alcohol allergy is not suitable for FES-PET/ C.\n3. There are contraindications for patients who are expected to have metastasis puncture or surgery.\n4. Mental disorders or other conditions affecting patient compliance.",
    "sex": "MALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}